About Us


Just like our name “Quan” (meaning “Fountain/Spring” in Chinese), we discover, incubate and grow next-generation life sciences companies. Our unique investment philosophy enables us to explore disruptive solutions to critical healthcare problems impacting the lives of millions. Our portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that will generate significant value to patients. In addition, we are investing in leading players that fulfill the rapid growing needs in a nascent innovation driven eco-system in China.

Empowered by strong expertise in both science and business, our investment professionals are able to identify and nurture the next generation of great companies. We are deeply involved in company building and hands-on to support strategy, operation, and development. We contribute broad networks to bridge and smooth companies’ transformation between different development stages, and maximize the company value across value chain and varying geographies.

Investment Strategy

We identify, incubate and invest in innovative early and growth stage companies globally and in China, with focus on:


  • Therapeutic biotech/pharma
  • Enabling technologies/High-end specialty services
  • Companion diagnostic & Precision medicine

Our Value Added

We provide “smart capital” that brings:


  • Broad scientific knowledge
  • Cross-functional operational experiences
  • Deep company-building leadership guidance
  • Extensive global & local network
  • Unique combination of global vision/quality and China strength
Samantha Du

Founding Managing Director

Marietta Wu

Managing Director

Stella Xu

Managing Director

Rick Xu

Venture Partner

John Wong

Venture Partner

Peter Wirth

Senior Advisor

Angela Shen


Yingying Yang


Zhanghang Yan

Vice President

Kui Wang

Senior Associate

Xiao Wang


Crystal Yin

Director, Finance

Stacy Sun

Senior Accountant

Lena Guo

Operation Manager

Cherry Jin

Executive Assistant